경비 약물전달 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 약물 유형별, 제형별, 치료 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

The Global Nasal Drug Delivery Market, valued at USD 59.67 Billion in 2024, is projected to experience a CAGR of 7.66% to reach USD 92.91 Billion by 2030. Nasal drug delivery involves administering therapeutic agents directly to the nasal cavity for local or systemic absorption, utilizing its rich vascularization and the potential for direct brain access. Main drivers supporting this market's growth include increasing patient preference for non-invasive drug administration, the rapid onset of action, and the avoidance of hepatic first-pass metabolism, which collectively enhance drug bioavailability and therapeutic efficacy. The rising prevalence of chronic respiratory conditions and the demand for convenient self-administration methods also notably contribute to market expansion.

Key Market Drivers

The increasing patient preference for non-invasive drug administration significantly influences the growth trajectory of the global nasal drug delivery market. Patients often favor routes that minimize discomfort and inconvenience, promoting better adherence to treatment regimens, particularly for long-term therapies or conditions requiring frequent dosing. This preference is evident in a broad range of therapeutic areas, driving pharmaceutical companies to develop and optimize nasal formulations for conditions traditionally managed by injectables.

Key Market Challenges

The inherent limitation of drug permeability across the nasal mucosal barrier presents a significant constraint on the growth of the Global Nasal Drug Delivery Market. This physiological hurdle complicates the formulation and effective systemic or even local delivery of large molecule pharmaceuticals, such as peptides, proteins, and antibodies. These larger therapeutic agents often struggle to traverse the tightly regulated nasal lining, hindering their optimal absorption into the bloodstream or direct access to the brain.

Key Market Trends

Nose-to-brain delivery for central nervous system (CNS) therapeutics represents an emerging and highly promising approach that exploits the unique anatomical pathways of the nasal cavity to bypass the blood-brain barrier and deliver drugs directly to the brain. This targeted route enables higher therapeutic concentrations in the CNS while reducing systemic exposure and minimizing associated side effects. As a result, it offers significant potential for the treatment of complex neurological and psychiatric disorders, including Alzheimer's and Parkinson's diseases, where conventional delivery methods often face limited efficacy.

Key Market Players

• GlaxoSmithKline Plc
• Pfizer, Inc.
• AstraZeneca PLC
• Novartis AG
• Becton Dickson & Company
• Cadila Pharmaceuticals Ltd.
• 3M Company
• Johnson & Johnson
• Sanofi S.A.
• Merck & Co., Inc.

Report Scope:

In this report, the Global Nasal Drug Delivery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nasal Drug Delivery Market, By Drug Type:

• Antihistamines
• Corticosteroids
• Anesthetics
• Antibiotics
• Pain Relief Drugs
• Others

Nasal Drug Delivery Market, By Dosage Form:

• Sprays
• Drops
• Powder
• Gels & Ointments

Nasal Drug Delivery Market, By Therapeutic Application:

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Rhinitis
• Cystic Fibrosis
• Nasal Congestion

Nasal Drug Delivery Market, By End User:

• Home Care Settings
• Hospitals
• Clinics

Nasal Drug Delivery Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Nasal Drug Delivery Market.

Available Customizations:

Global Nasal Drug Delivery Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nasal Drug Delivery Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Drug Type (Antihistamines, Corticosteroids, Anesthetics, Antibiotics, Pain Relief Drugs, Others)
  • 5.2.2. By Dosage Form (Sprays, Drops, Powder, Gels & Ointments)
  • 5.2.3. By Therapeutic Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion)
  • 5.2.4. By End User (Home Care Settings, Hospitals, Clinics)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Nasal Drug Delivery Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Drug Type
  • 6.2.2. By Dosage Form
  • 6.2.3. By Therapeutic Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Nasal Drug Delivery Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Drug Type
      • 6.3.1.2.2. By Dosage Form
      • 6.3.1.2.3. By Therapeutic Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Nasal Drug Delivery Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Drug Type
      • 6.3.2.2.2. By Dosage Form
      • 6.3.2.2.3. By Therapeutic Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Nasal Drug Delivery Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Drug Type
      • 6.3.3.2.2. By Dosage Form
      • 6.3.3.2.3. By Therapeutic Application
      • 6.3.3.2.4. By End User

7. Europe Nasal Drug Delivery Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drug Type
  • 7.2.2. By Dosage Form
  • 7.2.3. By Therapeutic Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Nasal Drug Delivery Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Drug Type
      • 7.3.1.2.2. By Dosage Form
      • 7.3.1.2.3. By Therapeutic Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Nasal Drug Delivery Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Drug Type
      • 7.3.2.2.2. By Dosage Form
      • 7.3.2.2.3. By Therapeutic Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Nasal Drug Delivery Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Drug Type
      • 7.3.3.2.2. By Dosage Form
      • 7.3.3.2.3. By Therapeutic Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Nasal Drug Delivery Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Drug Type
      • 7.3.4.2.2. By Dosage Form
      • 7.3.4.2.3. By Therapeutic Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Nasal Drug Delivery Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Drug Type
      • 7.3.5.2.2. By Dosage Form
      • 7.3.5.2.3. By Therapeutic Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Nasal Drug Delivery Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Drug Type
  • 8.2.2. By Dosage Form
  • 8.2.3. By Therapeutic Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Nasal Drug Delivery Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Drug Type
      • 8.3.1.2.2. By Dosage Form
      • 8.3.1.2.3. By Therapeutic Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Nasal Drug Delivery Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Drug Type
      • 8.3.2.2.2. By Dosage Form
      • 8.3.2.2.3. By Therapeutic Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Nasal Drug Delivery Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Drug Type
      • 8.3.3.2.2. By Dosage Form
      • 8.3.3.2.3. By Therapeutic Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Nasal Drug Delivery Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Drug Type
      • 8.3.4.2.2. By Dosage Form
      • 8.3.4.2.3. By Therapeutic Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Nasal Drug Delivery Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Drug Type
      • 8.3.5.2.2. By Dosage Form
      • 8.3.5.2.3. By Therapeutic Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Nasal Drug Delivery Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Drug Type
  • 9.2.2. By Dosage Form
  • 9.2.3. By Therapeutic Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Nasal Drug Delivery Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Drug Type
      • 9.3.1.2.2. By Dosage Form
      • 9.3.1.2.3. By Therapeutic Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Nasal Drug Delivery Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Drug Type
      • 9.3.2.2.2. By Dosage Form
      • 9.3.2.2.3. By Therapeutic Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Nasal Drug Delivery Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Drug Type
      • 9.3.3.2.2. By Dosage Form
      • 9.3.3.2.3. By Therapeutic Application
      • 9.3.3.2.4. By End User

10. South America Nasal Drug Delivery Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Drug Type
  • 10.2.2. By Dosage Form
  • 10.2.3. By Therapeutic Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Nasal Drug Delivery Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Drug Type
      • 10.3.1.2.2. By Dosage Form
      • 10.3.1.2.3. By Therapeutic Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Nasal Drug Delivery Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Drug Type
      • 10.3.2.2.2. By Dosage Form
      • 10.3.2.2.3. By Therapeutic Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Nasal Drug Delivery Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Drug Type
      • 10.3.3.2.2. By Dosage Form
      • 10.3.3.2.3. By Therapeutic Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Nasal Drug Delivery Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. GlaxoSmithKline Plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Pfizer, Inc.
• 15.3. AstraZeneca PLC
• 15.4. Novartis AG
• 15.5. Becton Dickson & Company
• 15.6. Cadila Pharmaceuticals Ltd.
• 15.7. 3M Company
• 15.8. Johnson & Johnson
• 15.9. Sanofi S.A.
• 15.10. Merck & Co., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer